{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T10:34:20Z","timestamp":1777804460311,"version":"3.51.4"},"reference-count":45,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.3892\/or.2017.5452","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T13:06:34Z","timestamp":1487077594000},"page":"2497-2505","source":"Crossref","is-referenced-by-count":22,"title":["Upregulation of p38 pathway accelerates proliferation and migration of MDA-MB-231 breast cancer cells"],"prefix":"10.3892","volume":"37","author":[{"given":"Hugo W.","family":"Huth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto D.","family":"Gravina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarbas M.","family":"Resende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo M.","family":"Goes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Ropert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"key":"key20180107224311_b1-or-37-04-2497","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1752-153X-7-91","article-title":"Potent anticancer activity of cystine-based dipeptides and their interaction with serum albumins","volume":"7","author":"Banerji","year":"2013","journal-title":"Chem Cent J"},{"key":"key20180107224311_b2-or-37-04-2497","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","article-title":"Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer","volume":"486","author":"Misale","year":"2012","journal-title":"Nature"},{"key":"key20180107224311_b3-or-37-04-2497","first-page":"4","article-title":"The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.","volume":"486","author":"Diaz","year":"2012","journal-title":"Nature"},{"key":"key20180107224311_b4-or-37-04-2497","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"key20180107224311_b5-or-37-04-2497","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"key20180107224311_b6-or-37-04-2497","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/pr.107.00106","article-title":"Mitogen-activated protein (MAP) kinase\/MAP kinase phosphatase regulation: Roles in cell growth, death, and cancer","volume":"60","author":"Boutros","year":"2008","journal-title":"Pharmacol Rev"},{"key":"key20180107224311_b7-or-37-04-2497","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1152\/physrev.00028.2011","article-title":"Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update","volume":"92","author":"Kyriakis","year":"2012","journal-title":"Physiol Rev"},{"key":"key20180107224311_b8-or-37-04-2497","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol Mol Biol Rev"},{"key":"key20180107224311_b9-or-37-04-2497","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: Promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"key20180107224311_b10-or-37-04-2497","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-15-0173","article-title":"The stress kinase p38\u03b1 as a target for cancer therapy","volume":"75","author":"Igea","year":"2015","journal-title":"Cancer Res"},{"key":"key20180107224311_b11-or-37-04-2497","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1947601913507951","article-title":"Role of p38 MAP kinase signal transduction in solid tumors","volume":"4","author":"Koul","year":"2013","journal-title":"Genes Cancer"},{"key":"key20180107224311_b12-or-37-04-2497","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key20180107224311_b13-or-37-04-2497","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1947601913486349","article-title":"The 2 faces of JNK signaling in cancer","volume":"4","author":"Tournier","year":"2013","journal-title":"Genes Cancer"},{"key":"key20180107224311_b14-or-37-04-2497","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol Cancer"},{"key":"key20180107224311_b15-or-37-04-2497","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrc2889","article-title":"IAPs: From caspase inhibitors to modulators of NF-kappaB, inflammation and cancer","volume":"10","author":"Gyrd-Hansen","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"key20180107224311_b16-or-37-04-2497","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/01635581.2012.630551","article-title":"Cancer cell signaling pathways targeted by spice-derived nutraceuticals","volume":"64","author":"Sung","year":"2012","journal-title":"Nutr Cancer"},{"key":"key20180107224311_b17-or-37-04-2497","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.soc.2013.06.011","article-title":"Targeting the NF-\u03baB pathway in cancer therapy","volume":"22","author":"Erstad","year":"2013","journal-title":"Surg Oncol Clin N Am"},{"key":"key20180107224311_b18-or-37-04-2497","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: Players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"key20180107224311_b19-or-37-04-2497","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00726-009-0385-x","article-title":"LyeTx I, a potent antimicrobial peptide from the venom of the spider Lycosa erythrognatha","volume":"39","author":"Santos","year":"2010","journal-title":"Amino Acids"},{"key":"key20180107224311_b20-or-37-04-2497","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3727\/096504009789735404","article-title":"Establishment and characterization of MACL-1 and MGSO-3 cell lines derived from human primary breast cancer","volume":"17","author":"Correa","year":"2009","journal-title":"Oncol Res"},{"key":"key20180107224311_b21-or-37-04-2497","doi-asserted-by":"crossref","first-page":"21096","DOI":"10.1074\/jbc.272.34.21096","article-title":"Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo","volume":"272","author":"Pierce","year":"1997","journal-title":"J Biol Chem"},{"key":"key20180107224311_b22-or-37-04-2497","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: A further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem J"},{"key":"key20180107224311_b23-or-37-04-2497","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrm3644","article-title":"Molecular control of the NEMO family of ubiquitin-binding proteins","volume":"14","author":"Clark","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107224311_b24-or-37-04-2497","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2174\/156800911797264734","article-title":"RNAi screening identifies TAK1 as a potential target for the enhanced efficacy of topoisomerase inhibitors","volume":"11","author":"Martin","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107224311_b25-or-37-04-2497","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.onc.1210768","article-title":"TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis","volume":"27","author":"Safina","year":"2008","journal-title":"Oncogene"},{"key":"key20180107224311_b26-or-37-04-2497","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1158\/0008-5472.CAN-09-1636","article-title":"Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells","volume":"69","author":"Chen","year":"2009","journal-title":"Cancer Res"},{"key":"key20180107224311_b27-or-37-04-2497","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.molonc.2013.10.003","article-title":"A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis","volume":"8","author":"Leelahavanichkul","year":"2014","journal-title":"Mol Oncol"},{"key":"key20180107224311_b28-or-37-04-2497","doi-asserted-by":"crossref","first-page":"20490","DOI":"10.1074\/jbc.272.33.20490","article-title":"Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase","volume":"272","author":"Kummer","year":"1997","journal-title":"J Biol Chem"},{"key":"key20180107224311_b29-or-37-04-2497","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1128\/MCB.23.11.3859-3871.2003","article-title":"Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a","volume":"23","author":"Bulavin","year":"2003","journal-title":"Mol Cell Biol"},{"key":"key20180107224311_b30-or-37-04-2497","first-page":"1604","article-title":"Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase","volume":"61","author":"She","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107224311_b31-or-37-04-2497","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1083\/jcb.200405167","article-title":"Topoisomerase II and histone deacetylase inhibitors delay the G2\/M transition by triggering the p38 MAPK checkpoint pathway","volume":"166","author":"Mikhailov","year":"2004","journal-title":"J Cell Biol"},{"key":"key20180107224311_b32-or-37-04-2497","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0959-437X(01)00270-2","article-title":"p38 and Chk1 kinases: Different conductors for the G(2)\/M checkpoint symphony","volume":"12","author":"Bulavin","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"key20180107224311_b33-or-37-04-2497","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7150\/ijbs.5.44","article-title":"Non-classical p38 map kinase functions: Cell cycle checkpoints and survival","volume":"5","author":"Thornton","year":"2009","journal-title":"Int J Biol Sci"},{"key":"key20180107224311_b34-or-37-04-2497","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cellsig.2016.05.009","article-title":"MEK2 controls the activation of MKK3\/MKK6-p38 axis involved in the MDA-MB-231 breast cancer cell survival: Correlation with cyclin D1 expression","volume":"28","author":"Huth","year":"2016","journal-title":"Cell Signal"},{"key":"key20180107224311_b35-or-37-04-2497","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1568026054985902","article-title":"The biology of p38 kinase: A central role in inflammation","volume":"5","author":"Schieven","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"key20180107224311_b36-or-37-04-2497","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BST20110676","article-title":"Roles of p38 MAPKs in invasion and metastasis","volume":"40","author":"del Barco Barrantes","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"key20180107224311_b37-or-37-04-2497","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-9255-11-23","article-title":"Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism","volume":"11","author":"Pal","year":"2014","journal-title":"J Inflamm (Lond)"},{"key":"key20180107224311_b38-or-37-04-2497","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.molcel.2011.08.011","article-title":"Context-specific regulation of NF-\u03baB target gene expression by EZH2 in breast cancers","volume":"43","author":"Lee","year":"2011","journal-title":"Mol Cell"},{"key":"key20180107224311_b39-or-37-04-2497","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/aps.2014.62","article-title":"Crotoxin induces apoptosis and autophagy in human lung carcinoma cells in vitro via activation of the p38MAPK signaling pathway","volume":"35","author":"Han","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107224311_b40-or-37-04-2497","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.leukres.2012.02.025","article-title":"The venom of the spider Macrothele raveni induces apoptosis in the myelogenous leukemia K562 cell line","volume":"36","author":"Liu","year":"2012","journal-title":"Leuk Res"},{"key":"key20180107224311_b41-or-37-04-2497","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/18465","article-title":"The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway","volume":"398","author":"Ninomiya-Tsuji","year":"1999","journal-title":"Nature"},{"key":"key20180107224311_b42-or-37-04-2497","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1074\/jbc.M108133200","article-title":"Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1","volume":"277","author":"McDermott","year":"2002","journal-title":"J Biol Chem"},{"key":"key20180107224311_b43-or-37-04-2497","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/cdd.2014.123","article-title":"TAK1 control of cell death","volume":"21","author":"Mihaly","year":"2014","journal-title":"Cell Death Differ"},{"key":"key20180107224311_b44-or-37-04-2497","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.tips.2012.06.007","article-title":"Targeting of TAK1 in inflammatory disorders and cancer","volume":"33","author":"Sakurai","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"key20180107224311_b45-or-37-04-2497","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijms.2011.08.002","article-title":"Comparative phosphoproteome analysis reveals more ERK activation in MDA-MB-231 than in MCF-7","volume":"309","author":"Kabir","year":"2012","journal-title":"Int J Mass Spectrom"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2017.5452\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T22:55:23Z","timestamp":1515365723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,2,14]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.3892\/or.2017.5452"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5452","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]}}}